80089-4-1.jpg)
Abstract
The management of Hahnemann's ‘chronic diseases’ presents certain difficulties. In
particular the difficulty of finding a suitable homœopathic drug is noted.
Bach's and Paterson's work on bowel nosodes opened a totally new way of looking at
homœopathy and chronic disease (miasms). Since their time the homœopathic profession
has done little to take their research further.
Parallel to the work of Bach and Paterson continental bacteriologists and clinicians
developed therapeutic concepts based on intestinal microbes. Their research has become
internationally respected and is part of the new sciences of microecology (microbes
vs. host association) and gnotobiology (germfree research on animals). Both these
sciences allow for additional diagnostic and therapeutic insights that are relevant
to homœopathy.
Although the non-lactose fermenters, as defined by Bach and Paterson, are important
in chronic disease, other bacteria have equal significance. The ecology of microbe
and host, as expressed in their qualitative relatedness, needs to be better understood.
The author's effort over many years has been to correlate and integrate these modern
findings of bowel flora research and autogenous vaccines with his homœopathic practice.
It is suggested that, apart from the therapeutic benefits to be gained by this approach,
modern faecal bacteriology analysis could become a useful monitoring tool to evaluate
the response to medicines prescribed on homœopathic principles.
Key Words
Chronic disease - Bowel nosodes - Vaccine therapy - Microecology - Gnotobiology -
Symbiosis
